What Happened? Shares of life sciences company Neogen (NASDAQ:NEOG) jumped 14.1% in the pre-market session after the company reported its third-quarter 2026 ...
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...
Neogen (NASDAQ:NEOG) reported fiscal 2027 first-quarter revenue of $222.8 million, with core growth of 8.1%, as the company cited improved commercial execution, product-line strength in food safety and animal safety, and progress on its Petrifilm manufacturing transition.
Chief Executive Officer Mi
Life sciences company Neogen (NASDAQ:NEOG) reported calendar Q3 2026 (fiscal Q1 2027) results exceeding the market’s revenue expectations, with sales up 6.5%...
Life sciences company Neogen (NASDAQ:NEOG) will be announcing earnings results this Tuesday after market hours. Here’s what to expect. Neogen beat analysts’ ...
Neogen (NASDAQ:NEOG) shareholders approved all five proposals presented at the company’s 2026 annual meeting, including the election of three directors, advisory approval of executive compensation, and amendments to the company’s equity incentive and employee stock purchase plans.
Chair of the Boar
What Happened? Shares of life sciences company Neogen (NASDAQ:NEOG) fell 5.4% in the afternoon session after the U.S. Food and Drug Administration issued war...
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the ...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...
Over the past six months, Neogen has been a great trade, beating the S&P 500 by 8.3%. Its stock price has climbed to $11.93, representing a healthy 21% incre...
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
Life sciences company Neogen (NASDAQ:NEOG) reported Q2 CY2026 results topping the market’s revenue expectations, but sales were flat year on year at $225.3 m...
